Post COVID-19
13
1
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy Controls
Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
Virtual Physical Rehabilitation for Patients Living with Long COVID
Thromboembolic Complications in Mild Covid-19 Cases
Changes in Electrocardiographic (ECG) Ventricular Repolarization and Transthoracic Impedance Cardiography (ICG) Parameters in Patients with COVID-19 and After the Disease: Persistence and Prognostic Significance of These Changes
Endothelial Protection in Post COVID-19 Patients With Sulodexide
SELF-BREATHE RCT for Chronic Breathlessness
Multimodal Investigation of Post COVID-19 in Females
Value of Montelukast as a Potential Treatment of Post COVID-19 Persistent Cough
AIR-program and HUS Internet Therapy Compared to Treatment as Usual in Functional Disorders and Post Covid-19 Condition
A Telemedicine Brief Mindfulness Intervention in Post-COVID-19
Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients